UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042429
Receipt number R000047938
Scientific Title Usability of Texture and Color Enhancement Imaging (TXI), image enhanced endoscopy system, for diagnosing gastric cancer: a prospective trial
Date of disclosure of the study information 2020/11/16
Last modified on 2022/09/29 18:39:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usability of TXI for diagnosing gastric cancer

Acronym

Usability of TXI for diagnosing gastric cancer

Scientific Title

Usability of Texture and Color Enhancement Imaging (TXI), image enhanced endoscopy system, for diagnosing gastric cancer: a prospective trial

Scientific Title:Acronym

Usability of TXI for diagnosing gastric cancer

Region

Japan


Condition

Condition

superficial gastric neoplasms

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Usability of TXI for diagnosing gastric neoplasms

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of visibility for gastric neoplasms (white light imaging vs. TXI)

Key secondary outcomes

1. Visibility (GIF-H290Z vs. GIF-EZ1500 or GIF-XZ1200)

2. Correlation of characteristics of detectable or undetectable lesion in WLI or TXI

3. Detection rate in WLI or TXI

4. Inter-observer agreement


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Endoscopy (GIF-H290Z)

Interventions/Control_2

Endoscopy (GIF-EZ1500 or GIF-XZ1200)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. The patients with present history of gastric neoplasms

2. Patients who agree with the informed consent.

Key exclusion criteria

1.A Patient aged < 20
2. A patient who is pregnant
3. A lesion more than 8 cm

4.The patients who are evaluated inappropriate for the resear

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Dobashi

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-8463

Address

3-25-8 Nishi-shimbashi, Minato-ku, Tokyo

TEL

03-0344-1111

Email

ad99061@jikei.ac.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Dobashi

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-0861

Address

3-25-8 Nishi-shimbashi, Minato-ku, Tokyo

TEL

03-0433-1111

Homepage URL


Email

ad99061@jikei.ac.jp


Sponsor or person

Institute

The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Research fund of The Jikei University School of Medicine, Department of Endoscopy

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei University School of Medicine

Address

3-25-8 Nishi-shimbashi, Minato-ku, Tokyo

Tel

03-3433-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

32-156(10237)

Org. issuing International ID_1

IRB at The Jikei University School of Medicine

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 09 Month 14 Day

Date of IRB

2020 Year 09 Month 14 Day

Anticipated trial start date

2020 Year 10 Month 15 Day

Last follow-up date

2022 Year 09 Month 29 Day

Date of closure to data entry

2022 Year 09 Month 29 Day

Date trial data considered complete

2022 Year 09 Month 29 Day

Date analysis concluded

2022 Year 09 Month 29 Day


Other

Other related information



Management information

Registered date

2020 Year 11 Month 12 Day

Last modified on

2022 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047938


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name